LFG
SANA icon

Larson Financial Group’s Sana Biotechnology SANA Stock Holding History

Larson Financial Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,000
Closed -$71K – 3630
2025
Q3 		$71K Buy
+20,000
New +$72.3K ﹤0.01% 1031

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Larson Financial Group's SANA Position: Q4 2025 in Review

Larson Financial Group sold out of Sana Biotechnology (SANA) in Q4 2025, closing a stake of 20,000 shares — an estimated $71K sold.

Larson Financial Group first reported a position in SANA in Q3 2025 and held it in 1 quarter. The position peaked at $71K in Q3 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q4 2025.

  • Larson Financial Group reported no remaining Sana Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Larson Financial Group sold 20,000 Sana Biotechnology shares in Q4 2025, an estimated $71K.
  • Larson Financial Group first reported a position in Sana Biotechnology in Q3 2025 and held it in 1 quarter.
  • Larson Financial Group's Sana Biotechnology position peaked at $71K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2025.

Based on Larson Financial Group's 13F filing for Q4 2025, filed 6 Feb 2026.